A Life of PCOS - PowerPoint PPT Presentation

About This Presentation
Title:

A Life of PCOS

Description:

... 1999 Low-dose FSH Only a low-dose protocol should be used for ovulation induction in PCOS. ... Capable of inducing ovulation in PCOS (77%) ... – PowerPoint PPT presentation

Number of Views:38
Avg rating:3.0/5.0
Slides: 54
Provided by: Roy9212
Learn more at: http://www.hdhr.org
Category:

less

Transcript and Presenter's Notes

Title: A Life of PCOS


1
A Life of PCOS
  • Roy Homburg
  • Barzili Medical Centre, Ashkelon and Maccabi
    Medical Services, Israel
  • Homerton Fertility Centre, London




2
PCOS A typical case history
A life in 25 minutes of ..
Polly Sistik
3
Age 16, schoolgirl. c/o irregular periods, acne,
hirsutism. All symptoms started age 13.5 when had
first period, since then 3-4 periods/year.
o/e Obese BMI 31.5 Abdo circ. 92cm Acne face
and back Mild hirsutism
Polly Sistik
4
PCOS revised diagnostic criteria 2003 Rotterdam
consensus 2 out of 3 criteria required
  • Oligo- and/or anovulation
  • Hyperandrogenism (clinical and/or
  • biochemical)
  • Polycystic ovaries
  • Exclusion of other aetiologies

5
symptoms
OBESITY
hormones
ultra- sound
INSULIN
after Dewailly, 2003
6
(No Transcript)
7
(No Transcript)
8
Treatment aims options
Cure acne and hirsutism Regulate menstruation
  • Life-style changes
  • Anti-androgens / OC pill
  • ? metformin

9
symptoms
hormones
OBESITY
ultra- sound
WEIGHT LOSS
INSULIN
after Dewailly, 2003
10
(No Transcript)
11
HIRSUTISM/ACNETREATMENT
- Contraceptive pills
- Cyproterone acetate ethinyl estradiol
- Drosperinone ethinyl estradiol


- Cosmetic treatment
- Metformin not recommended as first line
treatment
12
Polly Sistik age 24
  • Engaged to be married.
  • BMI now 28
  • Amenorrhea for the last 6 months.
  • Wants to know her chances of conceiving.

13
72
14
Polly Sistik age 25
  • Married.
  • Trying to conceive for 6 months.
  • 4 periods in the last year.
  • Examinations
  • Treatment

15
Multiple Choice
  • Weight loss
  • Clomiphene citrate (CC)
  • Aromatase inhibitors
  • Insulin lowering medications
  • Low dose FSH
  • Laparoscopic ovarian drilling
  • IVF/IVM

16
Clomiphene
  • Homburg, Hum Reprod, 2005
  • n 5268 patients
  • Ovulation - 3858 (73)
  • Pregnancies - 1909 (36)
  • Miscarriage - 827 (20)
  • Multiple pregnancy rate - 8
  • Single live-birth rate 25

17
Should we give hCG in CC cycles?
NO NO Maybe Yes NO
  • Agarwal Buyalos, 1995
  • No improvement in conception rates
  • Deaton et al, 1997
  • No difference
  • Viahos et al, 2005
  • hCG may be beneficial
  • Kosmas et al, 2007 Meta-analysis
  • Favoured hCG but no significant difference
  • Brown et al, 2009, Cochrane review
  • No difference

18
Should we monitor clomiphene cycles with
ultrasound?
No U/S or hCG With U/S hCG
150 150 105 n
34.7 34.7 48 Cumulative pregnancy rate
26.7 26.7 35.6 Deliveries
1 1 0 Multiple pregnancies
  • Konig, Homburg et al, ESHRE, 2009

19
Reasons for Clomiphene Failure
  • Failure to ovulate
  • FAI
  • BMI
  • LH
  • Insulin
  • Ovulation
  • but no conception
  • Anti-estrogen effects
  • - Cervical mucus
  • - Endometrium
  • High LH

20
Clomiphene Citrate Treatment
21
Anti-estrogen effect on endometrium
  • Endometrial thinning in 15-50
  • (Gonen Casper,
    1990Dickey et al, 1993)
  • Causes ER downregulation and depletion.
  • Suppresses pinopode formation

  • (Creus et al, 2003)
  • No pregnancies when endometrial thickness at
    midcycle lt 7mm
  • Not dose related and recurs in repeat cycles
  • (Homburg et
    al, 1999)


22
Aromatase Inhibitor Treatment Day 3-7 of Cycle
ER
ER
ER
ER
E2
FSH
AI
Casper Mitwally
23
Aromatase InhibitorsTheoretical Advantages
  • Do not block estrogen receptors
  • No detrimental effect on endometrium
  • or cervical mucus
  • Negative feedback mechanism not
  • turned offless chance of multiple
  • follicular development

24
Clomiphene Citrate Treatment
CC
CC
ER
ER
ER
ER
ER
ER
E2
FSH
Day 10
Casper Mitwally
25
Aromatase Inhibitor Treatment
ER
ER
ER
ER
ER
ER
E2
FSH
AI
Day 5
Casper Mitwally
26
Aromatase InhibitorQuestions
  • Do they work?
  • Better than CC for first-line treatment?
  • Safety?

27
Aromatase Inhibitors vs CC
  • Meta-analysis, 4 RCTs
  • Clear superiority of aromatase inhibitors in
    pregnancy rates (OR 2.0) and deliveries (OR 2.4)

Polyzos et al, Fertil Steril, 2008
28
Letrozole vs CC
  • 911 newborns in 5 centers
  • CC Letrozole
  • Pregnancies 397 514
  • Congenital 19 (4.8) 14
    (2.7)
  • malformations
  • Major malformations 12 (3) 6 (1.2)
  • Total cardiac anomalies 1.8
    0.2

Tulandi et al, 2006
29
Aromatase Inhibitors
  • Letrozole 2.5-10 mg/day, n1102
  • Pregnancies 368 (33.4)
  • Miscarriages 99 (26.9)
  • Twins 2 (0.5)
  • Fetal anomalies 1 (0.2)

Aghssa et al, 2007 (PCOS, eds Allahbadia, Agrawal)
30
Metformin for ovulation induction?


31
Live birth rates
CC Metformin
CCmetformin 22.5 7.2
26.8
Legro et al, NEJM,
2007 15.4 7.9
21.1 Zain
et al, Fertil Steril, 2009
32
Insulin-sensitising drugs for women with PCOS,
oligo/amenorrhea and subfertility
  • Tang et al. Cochrane Database, 2009
  • There is no evidence that metformin improves live
    birth rates whether it is used alone or in
    combination with clomiphene, or when compared
    with clomiphene.
  • Therefore, the use of metformin in improving
    reproductive outcomes in women with PCOS appears
    to be limited.

33
Maitake mushroom
  • Chen JT et al, J Altern Complement Med, 2010
  • Maitake mushroom extract improves insulin
    resistance.
  • Capable of inducing ovulation in PCOS (77)
  • 6/8 CC resistant ovulated with CCMaitake

34
CONVENTIONAL REGIMEN WITH GONADOTROPHINS
75
75
75
5
5
5
5
DAYS
35
Results of Conventional Therapy14 series,
1966-1984, WHO I II
Hamilton-Fairley Franks, 1990
36
Low dose rec-FSH
100-150 IU
75-112.5 IU
50-75 IU
14
7
7
Days
37
Low dose gonadotropinsSummary of
resultsPatients - 841, Cycles 1556
Updated from Homburg Howles, 1999
38
Low-dose FSH
  • Only a low-dose protocol should be used for
    ovulation induction in PCOS.
  • Small starting and incremental dose increases
    recommended with no dose change for 14 days.

39
Duration of Initial Dose 14 or 7 Days?
14 days 7 days
N50, 107 cycles
FSH required - Amps 22
17 - Days 17.4 13 1 large
follicle/cycle 74 60 E2
(pmol/L) 1659
2072 Pregnancies 10 (40)
14 (56) OHSS 0
0 Multiple pregnancies 0
2/14
Homburg, 1999
40
Extended Study
Multiple pregnancies 14
days 0/10 7 days
6/29
Homburg, 1999
41
How long does it take?
  • With a starting dose of 75 IU FSH, unchanged for
    a minimum of 14 days, 90 will get to the
    criteria for hCGwithin 14 days

Homburg Howles, 1999
42
(No Transcript)
43
(No Transcript)
44
(No Transcript)
45
Factors affecting outcome of LOD for PCOS
  • CCR 54 after 12 months
  • 75 after 30 months
  • CC and low-dose FSH may be added if no ovulation
    after 3 months
  • One-off treatment with low multiple pregnancy
    rate and no OHSS
  • Best if lt 3 years infertility, thin and high LH

46
Maternal PCOS in pregnancy
  • Increased prevalence of
  • Early pregnancy loss
  • Gestational diabetes
  • Pregnancy induced hypertension
  • SGA babies

47
Polly Sistik age 44
  • Happy mother with 2 kids.
  • The future

48
Effect of aging on PCOS
  • Women with PCOS gain regular menstrual cycles
    when aging
  • Menstrual cycle restored in those with a smaller
    follicle count
  • Elting et al, 2000, 2003

49
Sleep Disorders in PCOSPCOS n53, controls n452
Risk of Sleep Apnea in PCOS Odds Ratio 29 (95
CI 5-294) Adjusted for differences in BMI
Vgontzas et al, JCEM, 2001

50
PCOS - Late sequelae
Hyperinsulinemia / hyperandrogenism / obesity
  • Diabetes mellitus x7
  • Hypertension x4
  • Low HDL/high LDL

All are risk factors for
cardiovascular disease and CVA
51
(No Transcript)
52
Polly Gone
53
Write a Comment
User Comments (0)
About PowerShow.com